Grogan Staging Calculator for ATTR Cardiac Amyloidosis
Biomarker-based staging
Enter the patient's cardiac biomarker values to determine the Grogan stage.
Both biomarker values are required. Values above the specified thresholds are classified as elevated.
The published 4-year overall survival estimates describe the original study cohort and should not be interpreted as an individualized survival prediction.
About the Grogan Staging System
The Grogan staging system is a biomarker-based prognostic classification developed in patients with wild-type transthyretin cardiac amyloidosis (ATTRwt-CM). It uses two cardiac biomarkers: cardiac troponin T and NT-proBNP.
Variables and thresholds
| Biomarker | Threshold | Elevated when |
|---|---|---|
| Troponin T | 0.05 ng/mL (50 ng/L) | >0.05 ng/mL |
| NT-proBNP | 3,000 pg/mL (3,000 ng/L) | >3,000 pg/mL |
Stage classification and reported outcomes
| Stage | Biomarkers above threshold | 4-year overall survival |
|---|---|---|
| I | Neither (0) | 57% |
| II | One (1) | 42% |
| III | Both (2) | 18% |
In the original report, stage III was associated with higher mortality than stage I after adjustment for age and sex (hazard ratio 3.6; p < 0.001).
Important application notes
- The original Grogan cohort comprised patients with ATTRwt; the system should not automatically be applied to ATTR variant (ATTRv) disease as though it had been derived in that population.
- This tool uses troponin T only. Troponin I is not a substitute for the original TnT criterion.
- At the exact threshold, a value is classified as not above threshold (≤); a value greater than the threshold is classified as elevated. This follows the threshold convention shown in the ACC staging summary.
- Biomarker assay characteristics, clinical context, renal function, and changes in treatment era can affect interpretation.
- The original survival estimates predate current disease-modifying ATTR therapies and should not be used as contemporary individualized prognoses.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.